Blai Coll's most recent trade in Structure Therapeutics Inc - ADR was a trade of 93,984 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 93,984 | 93,984 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 75,897 | 280,878 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 03 Mar 2026 | 11,826 | 204,981 | - | 21.0 | 248,228 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.74 per share. | 18 Sep 2025 | 8,106 | 216,807 | - | 7.7 | 62,767 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 284,241 | 284,241 | - | - | Employee Stock Option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 116,988 | 219,588 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 363 | 728 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 7,992 | 226,347 | - | 0 | Ordinary Shares | |
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 01 Mar 2025 | 1,434 | 224,913 | - | 6.8 | 9,804 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 01 Mar 2025 | 1,233 | 218,355 | - | 7.9 | 9,761 | Ordinary Shares |
| Structure Therapeutics Inc (ADR) | Blai Coll | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 429 | 1,157 | - | - | American Depositary Shares | |
| Structure Therapeutics Inc (ADR) | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 111,000 | 111,000 | - | - | Share option (right to buy) | |
| Structure Therapeutics Inc (ADR) | Blai Coll | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2024 | 90,600 | 102,600 | - | 0 | Ordinary Shares |